Focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. (NASDAQ: ANTH)
Investors 1
| Date | Name | Website |
| - | Sofinnova ... | sofinnova.... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 14.08.2008 | Anthera Ph... | Anthera Pharmaceuticals has ra... | - | - | venturebea... |
| 13.09.2006 | San Francisco’s Anthera Phar... | - | - | venturebea... |